HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 204 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,877,000 | -3.7% | 150,220 | 0.0% | 0.58% | -16.3% |
| Q2 2020 | $4,027,000 | +49.0% | 150,220 | 0.0% | 0.70% | +31.2% |
| Q1 2020 | $2,702,000 | +1.6% | 150,220 | +0.1% | 0.53% | +15.2% |
| Q4 2019 | $2,660,000 | -27.5% | 150,000 | -36.6% | 0.46% | -34.1% |
| Q3 2019 | $3,669,000 | -9.7% | 236,540 | 0.0% | 0.70% | -11.0% |
| Q2 2019 | $4,064,000 | +6.7% | 236,540 | 0.0% | 0.79% | -0.8% |
| Q1 2019 | $3,808,000 | +10.0% | 236,540 | 0.0% | 0.79% | -5.6% |
| Q4 2018 | $3,461,000 | – | 236,540 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |